Gene therapy for 'Longevity Protein' klotho begins human testing
NCT ID NCT07216781
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This early-phase study tests a gene therapy that delivers instructions for making Klotho protein, which is linked to brain and kidney health. Twenty-four healthy adults will receive a single injection to see if it safely raises Klotho levels and improves thinking or other body functions. The study focuses on safety and measuring changes in blood and urine markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apeiron Center
RECRUITINGAustin, Texas, 78701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
GARM Clinic
NOT_YET_RECRUITINGRoatán, Bay Islands, Honduras
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.